Insight
PBM Best Practices Series: What to expect from your PBM account team
Pharmacy benefit managers play a key role in helping plan sponsors manage prescription drug spend, and good account management can make all the difference
The GSE CRT market reopens post COVID-19 disruption: A new normal? Or more troubles on the horizon?
30 September 2020
This article takes a closer look at the COVID-19 disruption’s impact on the GSE CRT market—including subsequent changes to new issuance deal structure, pricing, and capital markets versus reinsurance allocation. Post-COVID-19 GSE CRT issuances have featured increased credit enhancement for issued tranches, increased pricing levels, tightened reinsurance versus capital markets pricing, and some changes in the reinsurance versus capital markets allocation.
Explore more tags from this article
About the Author(s)
INSIGHT
Related Milliman Insight
The GSE CRT market reopens post COVID-19 disruption: A new normal? Or more troubles on the horizon?
This article takes a closer look at the COVID-19 disruption’s impact on the GSE CRT market—including subsequent changes to new issuance deal structure, pricing, and capital markets versus reinsurance allocation.
Andrew Netter